Molbio Diagnostics Q1 FY27: Revenue Rs 411 Cr, swings to Rs 53 Cr profit
MOLBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Molbio Diagnostics reported Q1 FY27 total income at Rs 411.48 Cr versus Rs 100.47 Cr in Q1 FY26. EBITDA swung to Rs 103.68 Cr from a loss of Rs 14.50 Cr, with margin at 25.20%. PAT was Rs 52.74 Cr versus a loss of Rs 23.94 Cr. Growth was led by higher Truenat test-kit volumes across 12,500+ devices in 90+ countries. Note: about Rs 57 Cr of Q4 FY26 export orders were deferred to Q1 FY27 due to Gulf situation. Company recently listed on August 17, 2026 and is deploying IPO proceeds across capex and a Bengaluru R&D facility.
Strong turnaround with revenue and profits jumping sharply year-on-year. Likely positive for stock sentiment, though some revenue was deferred from prior quarter.